Diabetes Care Quality in the Veterans Affairs Health Care System and Commercial Managed Care: The TRIAD Study

  1. Eve A. Kerr, MD, MPH;
  2. Robert B. Gerzoff, MS;
  3. Sarah L. Krein, PhD, RN;
  4. Joseph V. Selby, MD, MPH;
  5. John D. Piette, PhD;
  6. J. David Curb, MD, MPH;
  7. William H. Herman, MD, MPH;
  8. David G. Marrero, PhD;
  9. K.M. Venkat Narayan, MD, MSc, MBA;
  10. Monika M. Safford, MD;
  11. Theodore Thompson, MS; and
  12. Carol M. Mangione, MD, MSPH
  1. From Veterans Affairs Ann Arbor Healthcare System, Center for Practice Management and Outcomes Research, and University of Michigan, Ann Arbor, Michigan; Centers for Disease Control and Prevention, Atlanta, Georgia; Kaiser Permanente, Oakland, California; Pacific Health Research Institute, Honolulu, Hawaii; Indiana University School of Medicine, Indianapolis, Indiana; University of Medicine and Dentistry of New Jersey–New Jersey Medical School, Newark, New Jersey; and David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, California.
    1. Figure. *Patients receiving care in one of the Translating Research into Action for Diabetes (TRIAD) study health plans or Department of Veterans Affairs ( ) health care systems and who had diabetes diagnosis based on the following criteria: a diagnostic code for diabetes (for example, 2 or more outpatient visits with an associated diabetes code [International Classification of Diseases, Ninth Revision, 250. ] or 1 or more inpatient stays with an associated diabetes code); a laboratory value suggestive of diabetes (for example, 2 or more hemoglobin A tests or diagnostic levels of hemoglobin A or fasting blood glucose); or a prescription for medications for diabetes (for example, insulin or an oral antidiabetic agent). †At the time of the survey, patients who met the initial criteria were included only if they verified that they had diabetes and received most of their diabetes care through the participating TRIAD health plan or a participating VA facility. CMC = commercial managed care.
      View larger version:
      Figure. *Patients receiving care in one of the Translating Research into Action for Diabetes (TRIAD) study health plans or Department of Veterans Affairs ( ) health care systems and who had diabetes diagnosis based on the following criteria: a diagnostic code for diabetes (for example, 2 or more outpatient visits with an associated diabetes code [International Classification of Diseases, Ninth Revision, 250. ] or 1 or more inpatient stays with an associated diabetes code); a laboratory value suggestive of diabetes (for example, 2 or more hemoglobin A tests or diagnostic levels of hemoglobin A or fasting blood glucose); or a prescription for medications for diabetes (for example, insulin or an oral antidiabetic agent). †At the time of the survey, patients who met the initial criteria were included only if they verified that they had diabetes and received most of their diabetes care through the participating TRIAD health plan or a participating VA facility. CMC = commercial managed care. Description of sampling and response rate.VAxx1c1c

    Responses to this article

    • Re: VA compared to Commercial Managed Care
      • Eve A. Kerr and
      • Carol M. Mangione, MD, MSPH; David Geffen School of Medicine at UCLA
      Ann Intern Med published online October 26, 2009
    • VA vs. "Managed Care"
      • Michael A. Patmas, MD, MMM, FACP.
      Ann Intern Med published online October 26, 2009

    Summary for Patients

    « Previous | Next Article »Table of Contents

    This Article

    1. Ann Intern Med August 17, 2004 vol. 141 no. 4 272-281
    1. AbstractFREE
    2. » Figures
    3. Full Text
    4. Full Text (PDF)
      1. Summary for Patients

    Current Issue

    1. November 17, 2009, 151 (10)
    1. Alert me to current issues